FDA.reportPublic FDA data

Fintepla 2.2 MG/ML Oral Solution

RxCUI
2381144
RxNorm name
Fintepla 2.2 MG/ML Oral Solution
Display name
Fintepla 2.2 MG/ML Oral Solution
Full name
Fintepla 2.2 MG/ML Oral Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FinteplaFENFLURAMINEUCB, Inc.e88f360e-33ad-4cd6-b2de-5ef885857c5d2025-10-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2381144

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e88f360e-33ad-4cd6-b2de-5ef885857c5dFintepla 2.2 MG/mL Oral Solution [PSN] · fenfluramine 2.2 MG/ML Oral Solution [Fintepla] [SBD] · fenfluramine 2.2 MG/ML (as fenfluramine HCl 2.5 MG/ML) Oral Solution [Fintepla] [SY] · Fintepla 2.2 MG/ML Oral Solution [SY]416These highlights do not include all the information needed to use FINTEPLA safely and effectively. See full prescribing information for FINTEPLA. FINTEPLA ® (fenfluramine) oral solution Initial U.S. Approval: 197320251027